This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Congenital indifference to pain (CIP, MIM #243000) is rare (<30 cases reported). We describe a consanguineous family from Egypt with the index patient displaying lesions typical of CIP. In addition, he had short stature, myopathy, and liver dysfunction—a combination typical of Navajo neurohepatopathy (NNH, MIM #256810). No mutation was found in MPV17, the gene primarily involved in NNH.1 Pain perception was normal in a sister with congenital liver disease. Detailed genetic and clinical investigation revealed two separate rare disorders in the index patient, glycogen storage disease type 3 (GSD III; MIM #232400) and CIP, based on homozygous mutations in the genes AGL and SCN9A.
Case report.
The index patient (IV-10, age 11 years) and his sister (IV-11, age 1 year 10 months) underwent detailed clinical assessment. Starting at 2 years of age, IV-10 developed frequent painless fractures of legs and arms, bruises, cuts, and abdominal enlargement. On recent examination, he had short stature (<3 SD), corneal ulcerations, self-mutilative injuries of lips, skin, and fingers, and limb deformities due to untreated fractures (figure). There was mild hypotonia in lower limbs, flexors of hips and trunk muscles, and hypesthesia in both arms. Liver enzymes (AST: 260 U/L, ALT: 607 U/L), creatine phosphokinase (CPK: 341 U/L), and serum triglycerides (214 mg%) were markedly elevated. Generalized decrease of bone density was noted (dual energy X-ray absorptiometry). Hepatosplenomegaly, hepatocyte swelling, and periportal fibrosis were consistent with GSD (ultrasonography, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
ACO2 homozygous missense mutation associated with complicated hereditary spastic paraplegia
Early-onset parkinsonism associated with PINK1 mutations
Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora
Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation